BioDelivery Sciences ‘pleased’ with mixed ruling over Opioid drug claims
21-12-2021
Feng Yu / Shutterstock.com
Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Monosol, BioDelivery, Belbuca, patent, PTAB, IPR
